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A MAJOR pathway of steroid
metabolism in rat mammary carcinomas
is the reduction of testosterone to 5a
dihydrotestosterone and 5a androstanediol
(King, Gordon and Helfenstein, 1964;
Miller, Forrest and Hamilton, 1974). In
vitro addition of oestradiol 17/? to incu-
bations of hormone-dependent rat
mammary carcinomas is associated with
an inhibition of 5a reduction of testo-
sterone (Miller, 1976a). The aim of the
present study was to determine if in vivo
hormone manipulation was associated
with similar changes.
A single i.v. injection of 5 mg 7-12-
dimethylbenzanthracene (DMBA) was
given to 24 randomly bred female Sprague
Dawley rats at 50 days of age. The size
of the tumours which were induced was
monitored twice weekly by measuring
with calipers 2 diameters at right angles.
When the tumours were 2 x 2 cm in
size, animals were allocated to one of
3 groups. Those in Group I were killed
without further treatment, those in Group
II were oophorectomized and killed 14
days later and those in Group III were
oophorectomized but 14 days later re-
ceived daily s.c. injections of 1 jug oestra-
diol in corn oil for a further 14 days,
when they were killed. In all animals,
oophorectomy ledtoregression oftumours;
all those subsequently given oestradiol
showed regrowth.
Tumours were harvested at death and
treated at 0°C. Each was finely sliced
in Krebs Ringer phosphate buffer pH 7-4
(10 ml/g tumour) and an NADPH-
generating system (200 ,umol glucose-6-
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phosphate, 30,tmol NADP and 50 u
glucose-6-phosphate dehydrogenase/g
tumour) and 7a3H-testosterone (45 jtCi/g
tumour) added. The incubation systems
were then shaken for 1 h at 3700 in an
atmosphere Of 02. The reaction was
stopped by adding methanol to 80% v/v
and the incubations stored at -10°C
until processed.
Before extraction, 500 ,tg of non-
radioactive carrier testosterone (17,8-
hydroxy-4-androstene-3-one), 5a di-
hydrotestosterone (17,8-hydroxy-5a-an-
drostane-3-one) from Sigma Chemical Co.
(St Louis, Mo.) and 5a androstanediol
(5a-androstane 3,8 17,/ diol) from Stera-
loids Inc. (N.Y.) were added to monitor
recovery losses. The metabolites were
extracted, separated into individual
steroids and purified by thin layer
chromatography as described previously
(Miller et al., 1974). The metabolism of
testosterone by conversion to 5ac dihydro-
testosterone and 5ca androstanediol were
determined by measuring the percentage
incorporation of radioactive label into the
appropriate metabolites after correction
for recovery losses.
The DNA content of the tumours was
determined by a modification of the
method of Burton (1956).
The pattern oftestosterone metabolism
by tumours from the 3 groups of animals
is shown in Table I. There was an
increased metabolism of testosterone in
tumours harvested 14 days after oophor-
ectomy, an effect reversed by administra-
tion of oestradiol 17,/. Tumours from
oestrogen-treated animals showed signifi-TESTERONE METABOLISM IN RAT MAMMARY CARCINOMAS
TABLE I.-Endocrine Status and Tumour Metabolism of 7cc3H-testosterone
Endocrine status
of animal
1. Intact*
2. Oophorectomized**
3. Oophorectomized***
+ oestradiol
t 1v2
2 v 3
1 v 3
% Testosterone
metabolized
Mean + s.e. (range)
% Conversion to
, A \~~~~~~
5o0 Dihydrotestosterone
Mean + s.e. (range)
5oa Androstanediol
Mean + s.e. (range)
53-10+5-05 (34.5-74-5) 15-50+3-90 (4 4-30 7) 13-95+1-50 (8 4-20 3)
66-50+±525 (53.5-88.0) 15*40+2-70 (5.5-30.1) 27*00±3*70 (16.4-49-1)
34-45+4-20 (16-8-51-5)
P <0O10
P < 0O01
P < 0-05
9-20+1-90 (3-6-19-2)
Not significant
Not significant
Not significant
14-20+2*45 (7-3-28 10)
P < 0.02
P < 0-01
Not significant
*Tumours from hormonally unmanipulated animals.
**Tumours from animals 14 days after oophorectomy.
***Tumours from animals oophorectomized but 14 days later given oestradiol (1 yg in corn oil) for a
further 14 days.
tSignificance between groups by Wilcoxon rank tests.
cantly less metabolism of testosterone
than those from either intact or oophor-
ectomized groups.
Although 5a dihydrotestosterone was
a metabolite oftestosterone in all tumours,
there was no significant difference in its
production between the animal groups,
despite a lowered mean production in the
group receiving oestrogen. In contrast,
the conversion of testosterone to its other
major 5ac reduced product, 5a andro-
stanediol, was clearly influenced by
hormone manipulation, and was
significantly increased in tumours from
oophorectomized rats. The subsequent
administration ofoestradiol was associated
with a significant decrease in production
of 5cx androstanediol, to levels comparable
with tumours from the intact group.
Sufficient material was available for
determination of DNA content in 6
tumours from each group. No significant
differences were observed (Table II).
TABLE II.-DNA Content of Tumours
Studied
DNA content
Endocrine status of animal (mg/g tumour + s.e.)
Intact (6) 7 00+0 74
Oophorectomized (6) 7 69 + 0 79
Oophorectomized +
oestradiol (6) 7 66 + 2 03
Figures in parenthesis are number of tumours
studied. No significant differences between the
groups by Wilcoxon-rank test.
These results indicate that, in female
Sprague Dawley rats bearing DMBA-
induced mammary carcinomas, oopho-
rectomy is associated with an increase in
tumour metabolism of testosterone, a
phenomenon which may be reversed by
in vivo administration of oestradiol. A
similar pattern was observed in the
conversion of testosterone to 5ac
androstanediol. Increased production of
5a androstanediol in tumours from
oophorectomized animals alone would
account for the higher levels of testo-
sterone metabolized by these tumours.
In contrast, reduced formation of 5ac
androstanediol does not fully account for
the decreased levels of testosterone
metabolized in tumours from oestrogen-
treated animals: reduced conversion to
5ac dihydrotestosterone in these tumours
also contributes to the decreased meta-
bolism oftestosterone.
As the DNA content of tumours from
each animal group was similar, these
changes are unlikely to be caused by
differences in tumour cellularity.
Furthermore, the decreased metabolism
and conversion of testosterone to 5ac
androstanediol following in vivo admini-
stration of oestrogen may be reproduced
in vitro by addition of oestradiol to
incubations of hormone-dependent rat
mammary carcinomas (Miller, 1976a).
Because the methods used in these
studies estimate the total production of
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all 4 isomers of 5ax androstanediol (Miller,
1976a), it is not possible to determine if
the production of a particular isomer is
preferentially affected by hormone
manipulation. However, only 17,?
isomers of androstanediol were identified
as metabolites of testosterone in human
breast cancer (Cameron et al., 1971).
It is possible that oophorectomy and
oestrogen administration affect tumour
metabolism indirectly, by respectively
lowering and raising circulating levels of
prolactin, to which the growth of DMBA-
induced tumours are particularly sensitive
(Meites, 1972; Pearson et al., 1972).
Nevertheless the in vitro addition of
oestradiol (Miller, 1976a), as well as
prolactin (Miller, 1976b), has been shown
to influence testosterone metabolism by
DMBA rat tumours and both hormones
may therefore be implicated in the
changes effected by the endocrine manipu-
lations described in this study.
Whether the effects of oestrogen ad-
ministration are caused directly by
oestradiol 17/l, or indirectly by prolactin
secretion, or both, the lower synthesis of
5a dihydrotestosterone and 5a andro-
stanediol in growing tumours from
animals given oestrogen, as compared
with regressing tumours after oophor-
ectomy, is in keeping with the growth-
inhibiting properties of5a reduced steroids
(Huggins and Mainzer, 1957). However,
without further work to determine the
sequence of events following hormone
manipulation, it is not possible to indicate
whether changes in steroid metabolism
occur before or concurrently with those
in tumour growth, or whether the change
in tumour growth itselfleads to differences
in metabolism oftestosterone.
The author thanks Professor A. P. M.
Forrest for his interest and encouragement
and the Cancer Research Campaign for
supporting this work.
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